As it is stated the trials are due to commence 'early 2021' one would think the financial side to this equation would be on the cards soon - are they going to raise funds alone or partner with a big player? I guess pros and cons to each option however if they partner up it will be very interesting to see what has been negotiated.
Ann: Opthea Completes Successful FDA and EMA Meetings for Phase 3, page-4
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
87.0¢ |
Change
-0.010(1.14%) |
Mkt cap ! $1.071B | |||
| Open | High | Low | Value | Volume |
| 88.0¢ | 88.0¢ | 86.0¢ | $3.927M | 4.510M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22861 | 87.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 88.0¢ | 28025 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |